Mia's Feed
Medical News & Research

Innovative Scoring System Aims to Reduce Unnecessary Carotid Artery Surgeries

Innovative Scoring System Aims to Reduce Unnecessary Carotid Artery Surgeries

Share this article

2 min read

A recent breakthrough in cardiovascular care introduces the Carotid Artery Risk (CAR) score, a new predictive tool designed to help doctors determine the most appropriate treatment for patients with clogged arteries. Traditionally, individuals with carotid artery blockages often undergo surgical procedures such as carotid endarterectomy or stenting to restore blood flow, but these interventions carry significant risks, including the possibility of stroke or other complications.

The CAR score enables clinicians to assess a patient’s specific risk of stroke over the next five years based on a combination of factors, guiding them toward personalized treatment plans. Patients identified as low or intermediate risk may benefit more from a conservative approach involving medications—such as cholesterol-lowering drugs, blood pressure management, blood thinners—and lifestyle modifications, rather than immediate surgical intervention.

In a clinical trial involving 428 adults from various hospitals across the UK, Europe, and Canada, those who received tailored medical therapy based on their CAR score experienced very low rates of strokes and heart attacks over two years. Interestingly, patients who underwent surgery did not demonstrate significant benefits compared to those managed with medication and lifestyle changes.

Senior researcher Dr. Martin Brown from University College London emphasizes that using the CAR score could help avoid unnecessary surgeries, reducing patient discomfort and medical risks, while also saving healthcare costs. This approach advocates for detailed individual risk assessments and intensive management of vascular risk factors.

The trial focused on patients showing symptoms related to artery narrowing, with participants being randomly assigned to receive either medication alone or combined with surgical procedures when deemed necessary. The treatments included dietary changes, cholesterol-lowering medications, blood pressure regulators, and blood thinners. The ongoing study aims to further validate these findings.

Experts like Dr. Louise Flanagan from the Stroke Association highlight that the CAR score offers a promising alternative to invasive surgery, potentially leading to safer, more effective management of carotid artery disease. While additional research is needed, this development marks a significant step toward personalized, less invasive stroke prevention strategies.

Source: https://medicalxpress.com/news/2025-04-scoring-unnecessary-surgery-clogged-arteries.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovations in Rugby Headgear: Can New Materials Reduce Long-Term Brain Injury?

Emerging research suggests that innovative headgear materials could reduce impact forces in rugby, potentially protecting players from long-term brain injuries despite not fully preventing concussions. Advances in technology aim to lessen the cumulative impact burden over players' careers.

Pulmonary Embolism in Children: A Growing Concern Recognized by New Research

New research reveals that pulmonary embolism in children is more common than previously believed. A large study highlights the need for increased awareness and updated diagnostic criteria in pediatric care.

Biomarkers Identified for Predicting Side Effects of Cancer Immunotherapy

New biomarkers identified by UT Southwestern researchers could help predict which cancer patients may develop side effects from immunotherapy, enabling more personalized and safer treatment approaches.

New Combination Therapy Shows Promise for Advanced Triple-Negative Breast Cancer

A groundbreaking clinical trial demonstrates that combining sacituzumab govitecan with pembrolizumab offers improved outcomes for patients with advanced PD-L1-positive triple-negative breast cancer, potentially revolutionizing first-line treatment options.